The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Oncologic Drugs Advisory Committee (ODAC). The general function of the committee is to provide advice and recommendations to the Agency on FDA's regulatory issues. The meeting will be open to the public. FDA is establishing a docket for public comment on this document.
Document
Oncologic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments
The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Oncologic Drugs Advisory Committee (ODAC). The general function of the co...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
82 FR 18296
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Oncologic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments,” thefederalregister.org (April 18, 2017), https://thefederalregister.org/documents/2017-07771/oncologic-drugs-advisory-committee-notice-of-meeting-establishment-of-a-public-docket-request-for-comments.